A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

The findings offer promising support for progressing ADPO-002NP treatment to first-in-human Phase I clinical trials. Adipo ...

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

We predict a price of $165.26. Obesity pill Amecrytin, which acts as an appetite suppressant without the effects of ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

While 1 in 10 Americans have diabetes, the rate in South Texas is much higher—estimated at 1 in 3 to 1 in 4 adults.

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

With a gain of more than 531% over the last 12 months, shares of Viking Therapeutics (NASDAQ: VKTX) are a hot commodity, to ...

Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer ...

Novo Nordisk A/S shares rose as surging sales of the blockbuster weight-loss treatment Wegovy reassured investors after rival ...